Nuveen Asset Management, LLC Biomarin Pharmaceutical Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,222,895 shares of BMRN stock, worth $80.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,222,895

Previous 1,061,602 15.19%

Holding current value

$80.1 Million

Previous $87.4 Million 1.65%

% of portfolio

0.02%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $11.1 Million - $15.1 Million	161,293 Added 15.19%	1,222,895 $86 Million
Q2 2024 Aug 09, 2024	BUY	$74.43 - $92.22 $15.4 Million - $19.1 Million	207,210 Added 24.25%	1,061,602 $87.4 Million
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $20.4 Million - $24.1 Million	242,978 Added 39.74%	854,392 $74.6 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $2.66 Million - $3.44 Million	34,905 Added 6.05%	611,414 $59 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $1.25 Million - $1.39 Million	-14,708 Reduced 2.49%	576,509 $51 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $426,638 - $493,676	4,922 Added 0.84%	591,217 $51.2 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $2.71 Million - $3.62 Million	30,890 Added 5.56%	586,295 $57 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $6.71 Million - $9 Million	-82,857 Reduced 12.98%	555,405 $57.5 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $394,943 - $465,990	-4,807 Reduced 0.75%	638,262 $54.1 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $2.21 Million - $2.68 Million	-30,907 Reduced 4.59%	643,069 $53.3 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $9.19 Million - $11.5 Million	-123,756 Reduced 15.51%	673,976 $54.7 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $1.11 Million - $1.41 Million	-15,422 Reduced 1.9%	797,732 $70.5 Million
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $12.7 Million - $14.5 Million	-169,862 Reduced 17.28%	813,154 $62.8 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $33.3 Million - $37.4 Million	-440,648 Reduced 30.95%	983,016 $82 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $4.51 Million - $5.47 Million	-60,324 Reduced 4.06%	1,423,664 $108 Million
Q4 2020 May 17, 2021	SELL	$72.61 - $90.2 $257,547 - $319,939	-3,547 Reduced 0.24%	1,483,988 $130 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $38.4 Million - $47.7 Million	-528,782 Reduced 26.23%	1,487,535 $130 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $77.1 Million - $141 Million	-1,072,692 Reduced 34.73%	2,016,317 $153 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $101 Million - $158 Million	1,269,435 Added 69.77%	3,089,009 $381 Million
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $68.6 Million - $93.1 Million	961,494 Added 112.05%	1,819,574 $154 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $27.1 Million - $36.4 Million	-421,396 Reduced 32.94%	858,080 $72.6 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $117 Million - $148 Million	-1,733,420 Reduced 57.53%	1,279,476 $86.2 Million
Q2 2019 Aug 15, 2019	BUY	$80.35 - $93.9 $242 Million - $283 Million	3,012,896 New	3,012,896 $258 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $270,139 - $351,952	-3,554 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $32,310 - $38,534	-416 Reduced 10.48%	3,554 $288,000
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $320,617 - $377,666	3,970	3,970 $0

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Biomarin Pharmaceutical Inc Transaction History